Marta Sobas

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Ralph Tiedt, Hui Hao-Shen, Marta Sobas et al. · Blood · 2007 · 430 citations · Full text

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 80 citations · Full text

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

Éric Lippert, François Girodon, E. Hammond et al. · Haematologica · 2008 · 76 citations · Full text

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Sabine Käyser, Ramy Rahmé, David Martínez‐Cuadrón et al. · Leukemia · 2020 · 49 citations · Full text

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd et al. · Blood Advances · 2022 · 41 citations · Full text